Health
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
Speed Read -
The pros and cons of privatising the NHS
Pros and Cons Our free health service is 'in crisis' but there are fears a move to a US-style insurance model could lead to 'a two-tier' system that prioritises profits over patients
By The Week Staff Last updated
Pros and Cons -
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
Speed Read -
America is leaving WHO. What does that mean for public health?
Today's Big Question Trump orders the withdrawal
By Joel Mathis, The Week US Published
Today's Big Question -
Why is the FDA slow to ban food additives?
Today's big question A legal loophole lets things slide
By Devika Rao, The Week US Published
Today's big question -
Is this the end of cigarettes?
Today's Big Question An FDA rule targets nicotine addiction
By Joel Mathis, The Week US Published
Today's Big Question -
The decline of the contraceptive pill
In the Spotlight Fears of the pill's side effects, stoked by social media, behind switch to fertility trackers – or no contraception at all
By Harriet Marsden, The Week UK Published
In the Spotlight -
Unprepared for a pandemic
Opinion What happens if bird flu evolves to spread among humans?
By William Falk Published
Opinion -
The UK's first legal drug consumption room
The Explainer 'Potentially transformative moment in UK drugs policy' as The Thistle opens in Glasgow
By The Week UK Published
The Explainer -
The 'wild west' of unregulated cosmetic surgery in the UK
The Explainer Complaints soar as aesthetics industry, selling Botox and fillers, remains largely unregulated
By Chas Newkey-Burden, The Week UK Published
The Explainer -
What are the long-term effects of alcohol?
It's not just cancer
By Joel Mathis, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
Today's Big Question -
Kidney stones are affecting children far more than they once did
Under the radar Salt may be to blame
By Devika Rao, The Week US Published
Under the radar -
Naltrexone: the wonder drug for alcoholism
The pill is said to have a high success rate in reducing alcohol cravings with few side effects
By Richard Windsor, The Week UK Published